date,title,source
Oct-17-18,"New Research Coverage Highlights Esperion Therapeutics, Summit Therapeutics, Ocwen Financial, Keane Group, Cellectis S.A, and Rapid7  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-18-18,Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),GlobeNewswire
